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Abstract
Cell migration is a fundamental process responsible for numerous physiological and 
physiopathological conditions such as inflammation, embryogenesis and cancer. This 
central aspect of cell biology has seen quantum leaps in our understanding of the coor-
dinated regulations, both spatial and temporal of numerous cytoskeletal proteins and 
their orchestrations. At the molecular level, this dynamic cellular process can be naively 
summarised as an engineered cycle composed of three distinct phases of (1) formation 
of cellular protrusion to initiate contact followed by (2) the adhesion with the external 
environment/cell-extracellular established connection and (3) the actomyosin force gen-
eration to consequently remodel the cytoskeleton. A prominent factor that regulates cel-
lular motility is S100A4, a protein that has received constant attention for its significant 
role in cellular migration. Consequently, and in order to focus further the impact of this 
work, the present chapter aims to review some of the actomyosin proteins/complexes 
that have been demonstrated to be crucial players of the cyclic migration process but are 
also S100A4 interactors. In doing so, this chapter aims to capture a picture of how expres-
sion of this small, calcium-binding protein may, in essence, remodel at different levels 
the actin organisation and fulfil the motility engineered cycle of protrusion, attachments 
and contractions.
Keywords: S100A4, Actin, Arp2/3, formin, tropomyosin, myosin, Rho-GTPAses, 
Rhotekin
1. Introduction
Cellular motility has been an essential cellular phenomenon throughout phylogeny that has 
allowed organisms to survive, adapt and prosper in different environments. It is engrained 
in the chemoattraction and nutrient-seeking mechanisms in protozoa such as Dictyostelium 
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discoideum [1]; whilst in metazoan, it is found to be a key concept for physiological regulations 
during all aspects of life. For instance, cellular migration in the early stages of gastrulation 
allows the coordinated movements of progenitor cells for the subsequent development of 
the different layers of precursor tissues and organs [2, 3]. Equally important is the profound 
effects cellular migration occupies in the process of healing during wound closure and/or 
tissue regeneration undertaken by tissues of the mesenchyme or epithelium [4]. Cell motility 
also plays essential functions during all stages of the immune response, from the develop-
ment of mature effector cells, to endothelium trans-crossing and phagocytosis [5–7]. Given 
the indispensable roles of cellular migration in these events, and others, it is therefore not 
surprising to learn that loss of functions of many actin-regulating genes result in embryonic 
lethality or severe immunodeficiency syndromes [8].
Other than these physiological conditions, cellular motility is essential in regulating some of 
the physiopathological steps seen in disease. As example, it is well-documented that cellular 
migration is one of the prominent factors involved in the later stages of carcinogenesis and 
the subsequent phases of metastasis [9–11]. Cancer cell dissemination is clearly dependent 
upon the ability of migratory tumour cells to evade away from their initial niche, leading to 
the colonisation and formation of distant secondary lesions in the body [12].
At the molecular level, cell migration requires the coordinated regulations, both spatial and 
temporal of numerous cytoskeletal proteins, to orchestrate the dynamic cellular processes 
needed for cells to acquire movement. In this context, the actin cytoskeleton and the closely 
linked myosin network play essential functions [13, 14]. The process of cellular motility can 
be summarised as an engineered cycle composed of three distinct phases which are, (1) for-
mation of cellular protrusion in the forms of lammelipodia and fillopodia to initiate contact 
and adhesion with the external environment, (2) regulation of cell-extracellular matrix estab-
lished connections, usually integrin-dependent, and (3) force generation by the actomyosin 
network which will control both the structure and organisation of the motile architecture [15]. 
I provide here a brief overview of some of the different elements and protein complexes that 
are regulated during this migratory cycle, focusing primarily on specific components of the 
actomyosin complexes.
A group of low-molecular weight polypeptides that has been demonstrated to have key func-
tions in remodelling the overall actin cytoskeletal network is the S100 protein family [16]. 
Composed of approximately 25 members, the presence of the majority of these in different 
cellular systems, both in vivo and in vitro has been associated with significant changes in 
cellular migration. One of the most prominent members of this family to have been linked to 
regulate cellular motility is S100A4, a protein that has received constant attention for its sig-
nificant role in promoting cancer metastasis [16–18]. Consequently, and in order to emphasis 
the impact of this work and strengthened its delivery, I have concentrated our attentions on 
actomyosin proteins/complexes that have both been demonstrated to be crucial players of 
the migration process but also S100A4 interactors. In doing so, this chapter aims to capture a 
picture of how expression of this small, calcium-binding protein may in essence remodel at 
different levels the actin organisation and fulfil the motility engineered cycle of protrusion, 
attachments and contractions.
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2. The actomyosin machinery in cellular migration
Motility can be seen as a lone activity where a single cell may migrate (also known as amoe-
boid or mesenchymal migration [19, 20]) or is referred to as collective, if this effort is the 
result of concerted effort undertaken by numerous cells, either in sheet or clusters [9]. Equally 
important is the cell physiognomy that will be regulated in the process. Mesenchymal motil-
ity as seen during fibroblast migration leads to cellular characteristic of a more elongated 
spindle-like shape. In this type of migration, an actin-rich leading edge can be observed, 
where extension of the front leading edge is driven by actin polymerisation [21]. In amoeboid 
migration, cells adopt a more rounded morphology and rely on the contraction-based mem-
brane blebbing and enriched levels of myosin II at the cell rear [22]. Both of these migratory 
processes have been shown to play important roles in both physiological and pathological 
events.
The complexity of the different types of cell migration that can be used is mirrored by the 
number of different molecular pathways that are available to orchestrate these processes. 
Among them, however, the remodelling of the actin cytoskeleton and its organisation stands 
as an irreplaceable circuitry which is undisputably common to all. At the molecular level, this 
network is considered to provide the platform where physical forces will be exerted. Pushing 
forces generated by the assembly of filamentous actin (F-actin) will encourage the forma-
tion of cellular protrusions, such as filopodia, lamellipodia, blebbing and the most recently 
characterised invadopodia [23–25]. These changes in actin polymerisation and their dynamics 
will be directly responsible for reshaping and remodelling the underling plasma membranes.
2.1. Cellular protrusions and regulators
Actin polymerisation. The actin filaments are considered to be the backbone of cellular protru-
sion, providing the physically necessary special platform that will provide sufficient force to 
deform the plasma membrane. Their overall organisation relies primarily on their polymeri-
sation from monomeric globular actin (G-actin) into long arrays. This process is regulated by 
numerous partners but the core regulator lies in ATP hydrolysis to promote actin molecule 
recognition and bonding between two monomers. When ATP bound G-actin is hydrolysed, 
the newly created ADP+Pi G-actin structure can form stable filaments. Binding of the nucleo-
tide takes place in the high-affinity binding site located in the deep upper inter-domain cleft 
of actin (Figure 1). The presence of a cleft around exposed subdomains II and IV results in the 
polarisation of the monomeric structure and is referred to as the pointed end (Figure 1). The 
other exposed side, composed of subdomains I and III is known as the barbed end [26] and 
constitute the major binding site for most actin binding proteins ([27], Figure 1). This is a very 
important distinction which will result in sticking difference in behavioural characteristics in 
both G-actin and F-actin, of which polarised polymerisation is only one aspect.
In the early stages of assembly, also known as nucleation, actin protomers aggregate in an 
energetically unfavourable process to form a dimer that is more likely to dissociate. Addition 
of another subunit stabilises the complex and represents the nucleus, a state where actin poly-
merisation is now more favourable than dissociation (Figure 1). The association of monomers 
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Figure 1. Actin structure and cartoon of F-actin polymerisation. (A) G-actin monomer at 1.54-Å resolution bound to ADP 
(PDB code 1J6Z) by Otterbein et al. [165] obtained from striated rabbit muscle tissue. Subdomain I (red, residues 1–32, 70–144 
and 338–374), subdomain II (yellow, residues 3369), subdomain III (green, residues 145–180 and 270–337) and subdomain 
IV (grey, residues 181–269) are highlighted, resulting in the orientation of the actin molecule with the pointed end (− end) 
and the nucleotide cleft in the upper part, and the barbed end (+ end) in the lower part. (B) Process of actin polymerisation 
highlighting the steps of nucleus formation and filament formation. Please note this is a schematic representation which 
does not illustrate the current model of actin polymerisation initially proposed by Holmes et al. [166] suggesting that actin 
filaments are structured as a two right handed long pitch helices of head to tail bound actin subunits or a single left handed 
short pitch helix with consecutive lateral subunits staggered with respect to another by half a monomer length.
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into a trimeric structure is seen as the rate limiting step of the whole polymerisation pro-
cess as it is reversible where monomers can easily dissociate [28–30]. It is during the stage of 
nucleation that addition of further actin subunits is supported at both ends. Once the nucleus 
and newly added monomers have been locked into position by conformational changes, the 
process of elongation begins and the addition of actin molecules at the barbed end of the 
filament can be seen, resulting in the formation of structural polarised complexes (Figure 1). 
Whilst G-actin subunits can self-assemble, this process only occurs if the concentration of 
actin exceeds a critical concentration.
Within cells, a growing number of binding partners, or actin-binding proteins, will act both 
antagonistically and agonistically to regulate the polymerisation process. Some factors will 
act as nucleators, such as formins and Arp2/3, facilitating the process through providing a 
scaffold structure which encourages de novo assembly. Others will regulate the overall struc-
ture of filaments through their remodelling in larger structures. Examples provided here will 
control the cross-linked state of actin filaments through the involvement of bundling regula-
tors such as the tropomyosins and to an extent myosins. Involvements of all these factors, 
as well as many others that are too numerous to be listed, here, will be responsible for the 
remodelling of the actin cytoskeleton into different substructures seen during cell migration 
(Figure 2).
When grown in a 2D environment, cells will encourage the formation of differential planar 
filamentous actin, in the form of filipodia/microvilli or sheet-like structures referred to as 
lamellipodia (Figure 2, [31, 32]). Whilst the former act as sensory organelles that enable cells 
to probe their local environment, through the formation of thin extensions that are mainly 
made of long, unbranched bundles, the latter is viewed as the main driving force for locomo-
tion, through the organisation of short branched actin networks (Figure 2). In both instances, 
however, regulation of F-actin polymerisation, especially at their barbed end is essential, in 
order to control their elongation in the direction of the plasma membrane and is thought to 
require nucleation-promoting factors where both formins and Arp2/3 have been shown to 
play key functions (Figure 2, [31, 33]).
Formins. The family of formins, encoded by 15 different genes in mammals represent a clus-
ter of large multi-domain proteins, grouped in eight different subfamilies, that regulate actin 
nucleation and polymerisation, primarily at the barbed end [34, 35]. Their nucleation abilities 
are regulated by signature regions of the proteins, the formin homology domains 1 and 2 
(FH1/FH2), located at the C-terminus (Figure 3). Although a clear picture as to how formins 
nucleate the assembly of actin filament is still under investigation, the C-terminal region has 
been demonstrated to be a key regulator as it recruits actin monomers in the presence of 
profilin. The FH2 domain also plays key function during the polymerisation of F-actin as it 
allows addition of large amounts of actin subunits at the barbed end [36]. This continuous 
tracking results from alternate contact of the two halves of the FH2 domain with the two 
most terminal actin subunits in the filament, allowing the sliding of the whole formin mol-
ecule through an open/closed conformation as the subunits, remaining bound as subunits are 
added [37–39]. For some formins, activation is also controlled through the release of the head 
to tail auto-inhibition as well as through the movement of proteins away from the leading 
edge [40]. For such formins, classified as diaphanous-related formins (DRF) [41], comprised 
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of 4 families; diaphanous (Dia including mDia), Dishevelled associated activators of mor-
phogenesis (Daam), formin-like proteins (FMNL) and FH1/FH2 domain-containing proteins 
(FHOD) in mammals, the auto-inhibitory mechanism relies on the folding of the N-terminal 
portion, containing domains FH3, which physically obstructs the diaphanous autoregulatory 
domain (DAD) at the C-terminus and prevents it to interact with actin molecules (Figure 3, 
[42]). Binding of the Rho-GTP to the formin polypeptide in the GBD (GTPase binding domain) 
region is thought to result, at least in part, to the displacement of the masking DAD region 
away from the FH3 domain [43]. Molecular mechanisms to explain this process are currently 
being investigated. The relocalisation of formin to the leading edge is also a key concept to 
control their activities. Membrane relocalisation has been reported to be performed primarily 
by Rho-GTPases through their binding to the GBD [44]. Other studies have also revealed that 
Figure 2. S100A4 interacting actomyosin complexes and their simplified organisation in the different protrusions of a 
migrating cell. (A) Actin and focal adhesion organization in a HeLa migrating cell. Staining for F-actin using Phalloidin-
rhodamin (red) and paxillin with antibodies coupled to FITC (green) in a migrating HeLa cell. In this image, the actin 
mediated structures of the filopodium and lamellipodium/lamellum are distinctly visible at the leading edge of the cell. 
B and C present models for the lamellipodium/lamellum and filopodium and the respective molecular organisation 
within, focusing on the proteins presented in this chapter. (B) A simplified model for lamellipodium/lamellum 
formation. In the lamellipodium, the Arp2/3 complex via activation by WASP/WAVE complex interacts with actin 
filaments resulting in the nucleation of new actin filaments from the side of existing filaments. Formin proteins are also 
found at the barbed end of filaments. Limprin and the Rho-GTPase-Rhotekin complexes could get regulated by S100A4 
to promote lamellipodia protrusions. In the lamellum, tropomyosin wrapping around the actin filaments prevents 
interactions with other actin binding proteins. NMMIIA regulates retrograde flow in the lamellum. At the interface of the 
lamellipodium–lamellum, actin is depolymerised. Interactions of S100A4 with tropomyosins and the NMMII complexes 
have been reported and could result in significant changes in their overall organisation. (C) A simplified model for 
filopodia formation. In this diagram, actin polymerisation promoted by the Arp2/3 complex leads to the branching and 
extension of nascent individual actin filaments in the filopodium. Recruitment of the formins to this location promotes 
the elongation of the filaments through the addition of actin monomers at the barbed end. Other actin bundling proteins 
such as fascin regulates filopodia stability through the clustering of actin filaments. Both the Limprin and the Rho-
GTPase-Rhotekin complexes could be regulated by S100A4 to control filopodial protrusions.
Cytoskeleton - Structure, Dynamics, Function and Disease210
the FH3 and DD (dimerization domain) regions on mDia also mediate its membrane localisa-
tion [45, 46], indicating that other proteins capable of interaction with such domains could be 
efficient regulators. The liprin family have been suggested to possess such properties and have 
been put forward as another series of proteins which may affect formin cellular functions [47].
Arp2/3 complex. Another regulator of actin nucleation and polymerisation that plays a critical 
role in the process of formation of lamellipodia and filopodia structures is the 220kDa Arp2/3 
factor [48]. Composed of seven different subunits (ARPC1-5, Arp2 and Arp3), this complex 
promotes the formation of newly formed actin filament from the sides of existing filaments, 
forming a 70° side-branched network from pre-existing filaments [49, 50] (Figure 3). This 
property is predominantly the result of a striking similarity between the Arp2 and Arp3 pro-
teins and that of monomeric actin molecules [51], providing a mimicking dimer that serves 
as a cooperative docking for other actin subunits and in doing so, accelerates the nucleation 
Figure 3. Cartoon showing some of the regulation steps for different actin nucleating proteins. (A) Activation of the 
Diaphanous-related formin. Autoinhibition of the actin nucleating ability is due to the interaction of the C-terminal 
Diaphanous auto-regulation domain (DAD) with the N-terminal FH3 (Formin homology) domain. Rho-GTP Binding of 
the GTP bound Rho to the GTPase binding domain (GBD) region is thought to lead to a partial displacement of the DAD 
as well as relocalisation of the complex, resulting in the unfolding of the protein and the relieve of the autoinhibition 
(DD dimerization domain). (B) Cartoon representation of the Arp2/3 complex and nucleation of a branched filament. 
The Arp2/3 complex initially binds to the pointed end of the mother F-actin. Binding of the WCA domain of a nucleation 
promoting factor (NPF) to exposed regions of Arp2 and Arp3 allows the delivery of actin monomer and initiate the 
polymerisation of a nascent branched filament as elegantly demonstrated [52].
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process and thereby reduces the rate of the limiting step at this stage [52]. Whilst all com-
ponents of this hetero-heptamer are critical for the generation of newly formed actin arrays 
from the pointed end, albeit with distinct functions, the Arp2 and Arp3 proteins are seen as 
the principal components responsible for establishing the initial base of the newly assembled 
filament [52]. The other components, especially ARPC1, are mainly involved in the binding 
to the mother filament [53, 54] (Figure 3). Interestingly, weak basal activity of the purified 
Arp2/3 complex in promoting actin nucleation and branch formation [55, 56] highlights its 
intrinsic association with other regulators [57]. Activation of the Arp2/3 complex is regulated 
by different complexes at distinct cellular locations. Whilst Arp2/3 is controlled by the WAVE 
regulatory complex in a Rac-GTPase pathway in lamellipodia, the Wiskott-Aldrich syndrome 
protein family (WASP), downstream of Cdc42, is predominantly implicated with the regula-
tion of Arp2/3 in filopodia [58]. By all accounts, these nucleation-promoting factors (NPF) 
stimulate Arp2/3 mediated-nucleation through a WCA domain found at the C-terminus 
(Figure 3). It is thought that the WH2 region within the WCA domain is responsible for bind-
ing and therefore delivering the actin monomer, whilst the CA sequence promotes binding to 
the exposed regions of both Arp2 and Arp3 [59]. It is the clustering of the different subunits, 
along with the newly added actin molecule that encourages formation of a new nucleus and 
further actin polymerisation, resulting in the elongation of 70° side-branched network. Since 
the NPF family has been continuously expanding, it is now subcategorised into five groups 
including WASp and neural Wiskott-Aldrich syndrome protein (N-WASP), three SCAR/
WAVE proteins and the recently identified factors WASH, WHAMM and JMY [60].
Taken all together, actin polymerization at the leading edge is a vital process for cellular 
migration, through the orchestrations of events that will ultimately lead to different cellular 
protrusion events. In this section, different actin polymerization factors and their functions 
(Arp2/3 and Formin) were briefly explored. One should remember that this is only a prefer-
ential view in regards to their potential involvements through a S100A4-dependent process 
and that numerous other regulators not mentioned here play equally vital roles in the process 
of actin remodelling and cellular migration.
Away from the leading edge and the protrusions of the lamellipodia and filopodia, the array 
of filamentous actin is seen to exist as more bundling rather than the branched sheets reported 
previously, mainly due to the interaction of different actin-binding proteins. This contractile 
network is seen as a unique structural complex, spatially posterior to the lamellipodium, and 
is referred to as the lamellum [61].
2.2. Lamellum and cellular contractions
In the spatial arrangement of the lamellum, filaments are organised in different structures, 
known as stress, dorsal and ventral fibres; they are the result of interaction of the actin fila-
ments with different partners (Figure 2). It is in this context and primarily through the control 
of the tropomyosin and myosins that contractile forces are exerted to manipulate their overall 
organisation. Generation of such tensile forces is provided by the myosin network, mainly 
non-muscle myosin II (NMMII) which is responsible for the majority of the morphological 
and architectural reorganisations that promote cell movement.
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Tropomyosin. The tropomyosin (tpm) family is composed of four separate genes, TPM1-4 
which can be further subdivided, due to different alternative splicing and post-translational 
modifications, resulting in the presence of more than 40 tpm products [62, 63]. Interestingly, 
these isoforms have been shown to interact differentially with actin filaments, ensuing bio-
physical and dynamic property changes, as well as different subpopulations occurring in dif-
ferent locations and in abundance [64]. It is unclear today, how these association-promoting 
mechanisms are regulated over time and space, to result in such highly selective and discrimi-
natory organisation [65, 66], but all interactions necessitate dimerization as well as head to tail 
contact between individual complexes to form continuous actin/tropomyosin filaments [67]. 
The formation of these highly selective complexes is thought to seclude, or at least regulate 
the interactions of other actin-binding proteins with these actin filaments, therefore playing 
a major role in determining the functions of different filaments [68, 69]. For instance, the 
absence of tropomyosin in the leading edge is thought to be a predominant factor that allows 
specific branching of the actin network, since different isoforms have been shown to compete 
and inhibit the actin polymerisation of Arp2/3, at least in vitro [52, 70]. Equally important is 
the fact that tropomyosin has been implicated in the regulation and recruitments of NMMII 
in stress fibre formation [68], regulating both elasticity and stiffness [71]
The overall organisation of the actin cytoskeleton can also be dictated by actin bundling and 
contractile motor proteins. Binding of individual filaments, actin cross-linking and motor pro-
teins allow the formation of thicker, linear and either paralleled or antiparallel filamentous 
F-actin networks that can be found in all subcellular localisations. In the lamellum, the class 
II non-muscle myosin family has been shown to be a key regulator, participating in the bun-
dling of actin filaments and generating mechanical forces, which result in filaments sliding 
and/or contractions [72, 73].
Non-muscle Myosin II family. The myosin II family, which encompasses a group of 34 different 
isoforms, are expressed in all eukaryotes, except plants with 15 genes corresponding to the 
myosin II cluster. These myosin II motor proteins are exclusively expressed in non-muscles 
cells and can therefore be referred to as non-muscle myosin II (NMMII). In its fully formed 
state, the NMMII complex corresponds to a 525 kDa structure composed of six non-covalently 
associated polypeptides. The backbone of this is a homodimeric myosin heavy chain contain-
ing a head domain and a long coiled-coil rod domain, separated by a neck area. Two essential 
light chains and two regulatory light chains bind to this backbone [74]. The N-terminal head 
portion of the heavy chain is globular in structure and possesses the actin-binding domains as 
well as the ATPase activity which is required for movement towards the plus end of the actin 
filament, thereby inducing sliding between filaments and force generation. In contrast, the long 
coiled-coil C-terminal part of this protein is essential for dimerization and further assembly of 
one hexamer to another thereby forming a multimeric network of bipolar NMMII with motor 
domains positioned at both ends of the filaments. Bipolar filaments of NMMII formation are 
the result of electrostatic interactions between these C-terminal helical tails [75] and are essen-
tial for its cellular functions. Stability of these NMMII filaments is controlled by phosphory-
lation of the myosin heavy chain [76, 77] or by interaction with proteins that recognize the 
C-terminal helical tail region.
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NMMII isoforms in the form of NMMIIA, NNMIIB and NMMIIC are found in most, but not 
all human cells and most mammals. NMMIIA and NMMIIB are expressed at similar levels in 
endothelial and epithelial cells. There is, however, little or no NMMIIC present in these cell 
subsets although it is known to be much more prominent in cells of lung and nervous tissues. 
Their location appears to be cell-specific and will be regulated differentially depending on the 
type of cell migration. Perhaps their expression patterns further reflects their function, since 
NMMIIA and NMMIIB play fundamental roles in mediating cell shape and matrix interac-
tions during migration, whilst a clear role of NMMIIC in this process is still missing. As a 
consequence, during mesenchymal motility, NMMIIA is localised throughout the cells, in 
cellular protrusions and in both the lamellipodia and lamella of migrating cells [78] where, 
with Arp2/3-dependent actin polymerisation in the former, it results in actomyosin contrac-
tion and the retrograde flow of F-actin towards the cell body [61]. NMMIIB is predominantly 
found in the central and rear regions of the cell but not at the cell front [79].
Whilst formation of protrusions is a key element of cellular motility, it is equally critical that 
these newly created extensions also adhere and attach to the substratum, as their inability to 
do so result in their rearward movements in waves due to cellular tension [80]. Nascent adhe-
sions are the first observable adhesive structures established in the lamellipodium [72, 81]. 
Their transient nature will force them to either disassemble quickly or mature into larger 
complexes known as focal adhesions which reside at the boundary of the lamellipodium 
and lamellum [82]. Actomyosin contraction is the main regulator that controls nascent adhe-
sion enlargement [72]. This initial interaction with the extracellular environment will in turn 
induces activation of downstream effectors transmitted to the plasma membrane to encour-
age further integrin adhesion and clustering through their activation as well as changes in 
confirmation of extracellular matrix proteins [83]. Following on from this integrin activation, 
other downstream cellular pathways are also instigated; these lead to the recruitment, in a 
force dependent manner, of numerous framework and adaptor proteins which associate to 
form an adhesome [84]. Indeed mechanical stretch generated during this process induces 
changes in structural protein configurations, thereby encouraging binding of certain factors 
to other partners, as is the case for paxillin, vinculin, talin and actin, three essential component 
of the adhesome/adhesion complex [85, 86] (Figure 4).
NMMII cross-linking and contractile functions to remodel the actin cytoskeleton are regulated 
by phosphorylation of (1) regulatory light chains (RLC), (2) heavy chains (HC) and (3) myo-
sin’s ability to assemble into filaments. The RLC polypeptide can be specifically phosphorylated 
at different regulatory sites. The most prominent site is Ser19, leading, when phosphorylated, 
to a significant increase in ATPase activity of the head domain in the presence of actin [87]. 
Phosphorylation sites in the C-terminus of the myosin heavy chain have also been identified, 
although the true implications of such changes in ATPase activity remain unclear. Regulation of 
the reversible phosphorylation of specific residues is obtained through the activation of different 
kinases and phosphatases, depending on the residues considered. Whilst phosphorylation at 
residue Ser19 will be regulated by MLCK (myosin light chain kinase) and MYPT1 (myosin phos-
phatase target subunit 1), the most prominent examples, respectively [88, 89], the C-terminal 
region of the myosin heavy chain is directly targeted by kinases such as TRPM7 (transient recep-
tor potential cation channel subfamily M member 7) and PKC (protein kinase C) [77, 90].
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Figure 4. Myosin IIA expression in Cos7 cells regulates actin fiber formation and focal adhesion maturation. (A) 
Regulation of the actin organisation in Cos7 cells in the presence of NMMIIA. Cos7 cells were seeded into 24 well plates 
and left to incubate for 24 h. Cells were washed and fresh medium without antibiotics were added into each well 4 h prior 
to adding transfection mixture containing either the empty PeGFP-C3 plasmid (green cells labelled as A’) or the PeGFP 
plasmid expressing NMMIIA (green cells labelled B’). Following a 48-h incubation, cells were fixed, permeabilised and 
stained either for actin (Phalloidin-rhodamine (red)) prior to mounting and viewing by epifluorescence microscopy. 
Note that the expression of NMMIIA leads to significant increases in stress fibres formation (B’ where both NMMIIA and 
actin colocalise). (B) Focal adhesion organisation in Cos7 cells in the presence of NMMIIA. Cells grown as above were 
transfected with an empty PeGFP-C3 plasmid (green cells labelled as C’) or the PeGFP plasmid expressing NMMIIA 
(green cells labelled D’) prior to fixing, permeabilisation and immunostaining for paxillin using a mouse anti-paxillin 
primary antibody and a secondary anti-mouse rabbit Alexa-568 secondary antibody (red), prior to mounting and 
viewing by epifluorescence microscopy. Note that the expression of NMMIIA leads to significant increases in formation 
of paxillin cluster at the end of the myosin fibres (D’ where paxillin foci are seen).
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Compelling evidence also demonstrates that phosphorylation and interactions with the 
C-terminal region of NMMII regulate assembly of the complex into filaments. Such post-trans-
lational modifications also result in a change in overall structure. In its fully dephosphorylated 
form, the compact NMMII complex adopts an asymmetric state, unable to polymerise which is 
relaxed into an extended conformation following phosphorylation of RLC [91]. Phosphorylation 
of the C-terminal region of NMMII by kinases such as TRPM7 and PKC has also been shown to 
interfere with its abilities to form filaments [92]. Finally, it is predominantly through changes at 
the C-terminus, via the coiled-coil domain that NMMII assembly into filaments is controlled. 
Truncation experiments have demonstrated that the C-terminal region containing an ACD 
(assembly competence domain), as well as the C-terminal tail piece, are both important to pro-
mote correct assembly of NMMII into parallel and anti-parallel filaments [93, 94]
Another key regulator of motility is the cell’s ability to orchestrate the different contraction 
and tension forces that are necessary to promote movement. In this section, lamellum com-
ponents such as those of the NMMII and tropomyosin networks have been briefly reviewed. 
The overarching purpose here being once again to focalise the reader’s mind on certain com-
plexes, which are known interactors for the S100A4 proteins and could be key players in the 
process of motility observed when this protein is aberrantly expressed. Other pivotal factors 
that regulate motility via contractions have not been mentioned here but have been addressed 
in numerous other reviews and chapters [23, 95–101].
3. S100A4 protein regulation of the actomyosin cytoskeleton
Initially, referred to as mts1, FSP1, metastatin, p9Ka, PEL98, calvasculin, 42A and placental 
calcium-binding protein, S100A4 is a low-molecular weight acidic protein belonging to the 
S100 family. This small polypeptide is characterised, as all other members of this family, by 
a pair of calcium-binding helix-loop-helix regions referred to as EF-hand calcium-binding 
domains located at either side of the protein and separated by a hinge region [16, 102]. Over 
the years, S100A4 has received a large degree of interest in the field of cancer cell biology, 
since its expression is linked to increased motility and invasion directly promoting metastasis 
in animals, and it is now considered a potent marker for human metastasis and predictor for 
poor patient outcomes [17, 103]. Its expression is also observed in non-physiopathological 
states in different motile cell types in vivo, including those of the immune system (lympho-
cytes, macrophages and neutrophils) as well as mesenchymal fibroblastic cells. The biological 
implications of S100A4 expression on cellular migration are well-known [16], but the mecha-
nisms required to attain such phenotypic changes are not fully characterised. In this part of 
the chapter, I will review its interactions with the different actomyosin components that have 
been discussed, whether actin nucleating activators, actin binding proteins or myosin regula-
tors, highlighting how their functions are being affected in the presence of the S100A4 protein.
3.1. S100A4 regulates cellular protrusion
Expression of S100A4 has been correlated to significant changes in overall actin organisa-
tion and cellular extensions, with extensive increases in lamellipodia and forward protrusions 
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[104, 105] which, in turn, are thought to result in greatly enhanced cellular motility. Similarly, 
S100A4 has been found to be enriched at both the leading edge and in pseudopodia of migrat-
ing cells [104, 106]. A clear molecular explanation as to how S100A4 can regulate such pro-
cesses is currently lacking, but different hypotheses have been formulated in view of what is 
known about its different binding partners and regulatory functions.
Actin interaction. Direct interaction and binding of S100A4 with actin has been demonstrated. 
This process is obtained, in the presence of calcium ions, at a ratio of 3 to 5:1. This high ratio 
of S100A4 to actin is intriguing, especially in view of that of other actin-binding proteins, sug-
gesting possible oligomerisation of S100A4 with itself as well as its ability to cross-link actin 
filaments [107, 108]. Further association of S100A4 with actin stress fibres have been reported 
both in vitro and in vivo [108, 109], although it is important to highlight that it is unsure 
whether this interaction is the result of direct protein interactions or is the result of an associa-
tion of S100A4 with other actin-associated factors. To this date, the biological consequences 
of such a partnership have not been deciphered and the true role of their interaction remains 
to be elucidated.
Liprin interaction. S100A4 has been shown to interact with the liprin family of proteins and 
both can be seen to colocalise at the plasma membrane [110]. Interaction of these two proteins 
leads to reduction in phosphorylation of the liprin β1 molecule. Current thinking indicates 
that the liprin family of proteins are key promoters of cellular migration [47, 111]. Among 
possible functions to regulate cytoskeletal remodelling at the leading edge, liprins have been 
shown to interact with formin proteins and affect the appropriate localisation of the for-
min mDia to the plasma membrane. Their interaction is modulated by liprin binding to the 
FH3-DD domains on mDia, preferably when in the open configuration after Rho-GTPase acti-
vation (Figure 3, [47]). In cells, Liprin α1 has been shown to form a pentameric complex with 
another isoform, liprin –β1 as well as LL5 and ERC1/ELKS proteins. This complex is located 
primarily at the leading edge of migrating cells and stimulates lamellipodia formation [112] 
as well as integrin-mediated focal adhesion stability [113]. Other reports further demonstrate 
the essential functions of liprin on stabilising lamellipodia and invadopodia [114]. The true 
involvement of S100A4 in the regulation of liprin and/or formin activities is currently missing, 
but one could hypothesise that the three protein functions may be intertwined. Given that 
S100A4 expression has been linked to filopodia instability [105], and the critical known role of 
formins in the process [58], one could for instance speculate and put forward a new formin-
liprin-dependent function for this small calcium-binding protein.
Rhotekin interaction. S100A4 has recently been linked to into the Rho-GTPase pathway through 
its association with the scaffold protein Rhotekin. The Rho-GTPase family has been demon-
strated to be a key regulator of the actin cytoskeleton structure and organisation. Initially, 
their roles appeared to remodel the formation of stress fibres, myosin activities and focal 
adhesion formation through modulations of its two main effectors ROCK and mDia [115, 
116]. Activation of ROCK, a Rho-associated coiled- coil serine/threonine kinase, would result 
in phosphorylation of myosin phosphatases, which, in turn, would lead to increase phos-
phorylation of RLC and subsequent contractibility of NMMIIA (as discussed above). Actin 
polymerisation through the mDia axis would also be stimulated by ROCK and Rho-GTPase 
[116, 117], resulting in actin filament and ultimately fibre formation. More recent analysis 
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clearly demonstrates that Rho activity is a key in the process of restructuring the leading edge 
in migrating cells, particularly RhoA [118–121]. Activation of RhoA has further been demon-
strated to take place within a short distance of the leading edge, regulating cellular protrusion 
in the process, preceding the activation of other GTPases such as Rac1 and Cdc42 [120]. A 
ternary complex consisting of RhoA, Rhotekin and S100A4 has been shown to play a key role 
in hijacking this complex towards the leading edge to stimulate membrane ruffling in lieu of 
stress fibres [122]. S100A4 binding specifically to the Rho-binding domain of Rhotekin does 
not interfere with the association of the scaffolding protein with RhoA, and instead, leads to 
further activation of the complex, although the direct effectors of this process to fully explain 
how this enhances lamellae formation remain unknown [122].
NMMIIA interactions. The best studied S100A4 interacting partner is undoubtedly the 
NMMIIA heavy chain [92, 123–126]. Structural models have revealed that the S100A4 dimer 
binds both the C-terminal region of the coiled-coil ACD1 domain as well as the N-terminal 
part of the disordered tailpiece [127, 128]. Such interaction is thought to induce unwinding 
and destabilisation of the coiled-coil region, potentially disrupting intermolecular interac-
tion between myosin molecules and subsequent disassembly and losses in contractibility 
[123, 128, 129].
Recent evidence indicates that the retrograde flow exerted by NMMII impedes extension of 
the leading edge and subsequent rates of protrusions because of reduced actin polymerisation 
[130, 131]. Therefore, a reduction in contractile forces, as observed when NMMII activity in cells 
is inhibited by blebbsistatin, leads to significant decreases in actin retrograde flow in the lamel-
lum. This reduced flow leads, in turn, to subsequent increases in actin clustering into bundles 
at the lamellipodium–lamellum interface, and increased leading edge extension [132, 133]. The 
opposite experiment where activation of the NMMII complex is achieved through a Eph recep-
tor/RhoA/ROCK signalling pathway was found to inhibit lamellipodial extension [134].
It is therefore rational to suggest that one of the protrusion-promoting abilities of S100A4 may 
be directly linked to its ability to interfere with formation of myosin fibres and their role in 
protrusion formation. Experimental support for a S100A4-NMMIIA role in cellular protru-
sion was obtained when S100A4 overexpression in tumour cells led to significant increase 
in leading edge protrusive activity [104]. This change in phenotype was shown indirectly 
to be NMMIIA dependent since the exogenous addition of antibody targeted towards the 
NMMIIA-binding site mimicked the cellular behaviour [104]. Interestingly, a reverse experi-
ment also confirmed a clear role for S100A4 in this process, since S100A4 (−/−) macrophages 
demonstrated large amounts of over assembled NMMIIA filaments, leading to significant 
lamellipodia instability and reduced persistence [135]. Because NMMIIA has been clearly 
demonstrated to be the preferential cytoskeletal target for S100A4 to date, it is expected that 
their partnership may also influence the overall organisation of the actomyosin network in the 
lamellipodium and lamellum where the majority of the NMMIIA pools are located.
Whilst S100A4 expression in cells has undoubtedly been linked to regulation of cellular 
protrusions, mainly increases in lamellipodia and forward protrusions, and arguably being 
responsible at least in part for some of the enhanced cellular motility observed, the true molec-
ular processes responsible are yet to be fully characterized. In this section, S100A4 partners 
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such as Rhotekin, actin or liprin possibly found at the leading edge are presented in order 
to provide possible explanations as to how such biological properties may be regulated and 
it is expected that future researches will shed new lights into the true mechanisms that are 
involved in this process.
3.2. S100A4 functions in the lamellum and cellular contractions
Behind the cellular protrusion of the highly dynamic lamellipodium, the actomyosin net-
work contributes to cell migration through contractibility and substrate adhesion [61, 72, 81]. 
Although direct evidence of S100A4 being localised in the lamella of migrating cells is still 
lacking, numerous reports have highlighted potential regulatory functions of the S100A4 
within this subcellular fraction since its expression has been shown to lead to dramatic 
changes in numbers and organisation of focal adhesions and actin stress fibres [104, 105, 109, 
122, 128, 136]. I will briefly discuss here the different properties that S100A4 encompasses 
towards a remodelling of this cellular architecture.
Tropomyosin interactions. The ability of S100A4 to bind to tropomyosin has been put forward 
both in vitro and in vivo [137], but with relatively low affinity if at all [138]. The true con-
sequences of this interaction remain to be fully elucidated in regards to biological cellular 
consequences.
NMMIIA interactions. As discussed previously, binding of S100A4 leads to significant disas-
sembly of NMMIIA filaments. Mechanical forces exerted by the myosin network have been 
shown to be key regulators for the growth and maturation of focal adhesions since altering 
contractility using either inhibitors [139] or knockout studies [79] results in impeded matura-
tion and stabilisation. Although myosin is not physically present in the adhesion, it influences 
the process through its attachment to actin bundles with which adhesion is associated [79]. 
Whilst no direct evidence has been presented to demonstrate that S100A4 interacting with 
the myosin network results in the loss of adhesion of cells with their substratum, there is a 
compelling number of reports which have linked S10A4 expression to either stress fibre losses 
or reduction of focal adhesion stability or maturation [104, 105, 109, 122, 128, 136]. Similarly, 
regulating the assembly status of myosin via phosphorylation of sites in the C-terminal coiled 
coil and tailpiece regions have also been associated with reorganisation of the cytoskele-
ton and focal adhesions. Phosphorylation of serine residue S1943 results in disassembly of 
NMMIIA filaments [76] and leads in vivo to cytoskeletal reorganisation, whilst conversely 
inhibiting phosphorylation of the C-terminal tail pieces was shown to induce stabilisation of 
focal adhesion [140]. Other myosin-disassembling factors which bind to the C-terminal coiled 
coil and tailpieces regions such as S100P or lethal giant larvae have also been shown to regu-
late focal adhesions [141–143].
This final section briefly summarizes the best characterized and known S100A4 interactor, 
namely NMMII, in view of their high binding affinity, as well as by the number of reports 
highlighting their association. Yet again, whilst we are gathering further understanding 
related to their association and the different regions of the proteins that are responsible, a true 
model as to how their interactions regulate cellular motility remains elusive both theoretically 
and more importantly experimentally.




Controlling the actin cytoskeleton and the motility process is a key function, that when going 
awry, leads to significant pathological conditions. Not surprisingly, mutations or aberrant 
expression of all actin interacting proteins listed in this section have been liked to diseases, 
thought to be the result of significantly reduced cellular motility. Mutations in cytoplasmic 
actin have been related to autosomal dominant hearing loss [144]. Mutation or molecular 
mechanisms that result in changes of activity of actin-binding proteins, such as the nucleat-
ing facilitating protein complex Arp2/3 have been linked, albeit indirectly, to bacillary dys-
entery, as their functions are high jacked by the Shigella bacterial strains to disseminate in 
the colonic epithelium [145]. Involvement of the Arp2/3 complex and their regulator WASp 
have also been shown to lead to immunodeficiency and reduced platelet numbers, as the 
loss of WASp expression leads to the Wiskott-Aldrich syndrome [146]. Formin has also been 
linked to pathological conditions such as deafness [147] and immunity deficiencies, at differ-
ent levels, presumably because of the differential expression of formins isoforms in different 
cell systems [148]. Mutation in NMMII has also been associated with a multitude of defects 
[89], with for instance, loss in NMMIIA affecting platelet and leukocyte dysfunction, renal 
diseases, loss to cataracts formation and neuronal disorders [14]. Equally important is the 
fact that differential expression of these factors and/or their activations are also key regulator 
of changes in cell division and migration/invasion, playing a predominant role in tumori-
genesis and metastasis [14, 15, 149]. In this context, the high levels of S100A4 expression 
have also been shown to be significant determinant allowing cellular spreading and distant 
tumour formation. Beside its role in cellular motility through its interactions with actomyo-
sin components which have been discussed throughout, S100A4 has also been demonstrated 
to play key roles in both cellular motility through the interactions with other partners. Both 
the Wnt/· catenin [150] and the AKT/slug [151] pathways have been shown to be capable 
of regulation by S100A4, leading to changes in cytoskeletal architecture and overall cellu-
lar migration. Other signalling pathways such as the PI3K/AKT/mTOR [152] or the NF-kB 
[153] route have also been shown to be capable of activation by S100A4 leading to significant 
changes in migration but without directly linking this process to cytoskeletal reorganisation. 
Another important aspect of S100A4 ability to encourage cellular migration and potential 
chemotaxis relates to its presence in the extracellular matrix. In the context of this chapter, I 
have concentrated our efforts to consider cytoplasmic S100A4, where it is found at concentra-
tion as high as 10 μM [154]. Traces of the protein have, however, also been reported both in 
medium of cultured cells [155, 156] and in biological fluids [157, 158], whether physiological 
or pathological, where it is thought to regulate the activities of metalloproteinases [159] or 
cellular receptors such as annexin2/plasmin and RAGE [156, 160]. Perhaps not surprisingly, 
different approaches have been utilised to combat the S100A4 motility and invasion inducing 
capability through the isolation of inhibitors. The result of this early work has demonstrated 
that some of these inhibitors regulate the interactions of S100A4 with the actomyosin net-
work. For instance, trifluoperazine, a phenothiazine-based compound, has been reported to 
block S100A4 ability to depolymerise NMMIIA filaments [161, 162]. The true potential of this 
compound in cells and possibly in vivo, along with deciphering the mode of actions of other 
molecules that have been isolated as specific inhibitors of the S100A4 associated cell motility/
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invasion/metastasis [163, 164] will pave the way for the development of further drugs that 
can regulate S100A4 interaction with the actomyosin architecture.
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